4 results match your criteria: ""ANADETO" medical center[Affiliation]"
Weight loss treatment for COVID-19 in patients with NCDs: a pilot prospective clinical trial.
Sci Rep
May 2024
Faculty of Pathology and Forensic Medicine, Astana Medical University, Astana, Republic of Kazakhstan.
Unlabelled: COVID-19 comorbid with noncommunicable chronic diseases (NCDs) complicates the diagnosis, treatment, and prognosis, and increases the mortality rate. The aim is to evaluate the effects of a restricted diet on clinical/laboratory inflammation and metabolic profile, reactive oxygen species (ROS), and body composition in patients with COVID-19 comorbid with NCDs. We conducted a 6-week open, pilot prospective controlled clinical trial.
View Article and Find Full Text PDFAssociation between COVID-19 morbidity, mortality, and gross domestic product, overweight/ obesity, non-communicable diseases, vaccination rate: A cross-sectional study.
J Infect Public Health
February 2022
Semmelweis University, Dept. Pathophysiology, H-1088 Budapest, Vas u. 17, Hungary. Electronic address:
Article Synopsis
- The study investigates how factors like GDP, prevalence of overweight/obesity, NCD mortality, and vaccination rates impact COVID-19 morbidity and mortality across various countries.
- Data analysis from 218 countries reveals significant correlations between COVID-19 rates and various social and economic indicators, such as GDP and obesity statistics.
- Increased vaccination rates have a positive effect on reducing new COVID-19 cases, although the statistical significance is marginal, especially in non-island countries compared to global averages.
Response: non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatment.
Curr Med Res Opin
July 2019
f Faculty of Pathology and Forensic Medicine , Medical University Astana , "ANADETO" Medical Center, Astana, Kazakhstan.
Severe nonalcoholic steatohepatitis and type 2 diabetes: liver histology after weight loss therapy in a randomized clinical trial.
Curr Med Res Opin
January 2019
f Faculty of Pathology and Forensic Medicine , Medical University Astana, "ANADETO" medical center, Astana , Kazakhstan.
Objective: To evaluate the effectiveness of the fast weight loss method on liver steatosis, fibrosis, inflammation, glycemic and lipid features and body composition in patients with severe nonalcoholic steatohepatitis (NASH) and type 2 diabetes (T2D).
Methods: A 24 week open prospective randomized controlled clinical trial including 80 adult patients (aged 40-65 years) was performed. The patients after randomization were divided into two groups: the main group followed the fast weight loss method; the control group received conventional drug treatment.